Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Mild Dementia (Mild Dementia) is a state of mind disorder (memory, reason, attention, concentration, time orientation) with difficulty in the complex activities of everyday life (bank accounts, shopping, transportation, etc).The olive leaves contain several phenolic compounds, most important of which are oleo-European and hydroxytyrosol. The properties of the olive leaves have been attributed mainly to these two substances.
Mild Dementia (Mild Dementia) is a state of mind disorder (memory, reason, attention, concentration, time orientation) with difficulty in the complex activities of everyday life (bank accounts, shopping, transportation, etc)
The olive leaves contain several phenolic compounds, most important of which are oleo-European and hydroxytyrosol. The properties of the olive leaves have been attributed mainly to these two substances. The benefits of eating olive leaves (juice, snack) are summarized as follows:
One can easily observe the richness of olive leaves in trace elements, minerals - the role of Fe, Cu, Zn, Al and Hg in Alzheimer's disease is very important - and vitamins, making them a valuable nutritional tool for humans. At the same time, their fatty acid (saturated, monounsaturated, polyunsaturated) ratio is ideal and indicates their cardioprotective and neuroprotective properties.
The presence of vitamin E is twice as high as that found in a proportion of sesame oil (4.1 mg / 100gr), making the olive leaves a food rich in that vitamin. As far as iron is concerned, its presence is greater than the corresponding presence of breakfast cereals (8.2mg / 100gr), so advertised as a complete and quality food for the modern man.
Finally, particular reference should be made to the dietary fiber of the olive leaves. The dietary fiber is found in this food in abundance, making it a food that helps in the multifactorial treatment of constipation.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Beverage of Olive Oil Leaves | Experimental | 50 patients Beverage of Olive Oil Leaves |
|
| Mediterranean dietary protocol Intervention | Active Comparator | 50 patients Dietary Supplement: Dietary Supplement:Mediterranean Diet |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Beverage of Olive Oil Leaves | Other | Beverage of Olive Oil Leaves,Oleuropein |
|
| Measure | Description | Time Frame |
|---|---|---|
| Neuropsychological Assessment - Measurements to Assess General Cognitive Function | Changes in Mini-Mental State Examination (MMSE) score Score scale:0-30,cut off:24 | baseline,24 months |
| FUCAS-Measurements to Assess Daily Functionality | Changes in Functional cognitive assessment scale (FUCAS) score Score scale:42-126,cut off:42 | baseline,24 months |
| Letter & Category Fluency Test- Measurement to Assess Verbal Fluency and Learning | Changes in the Letter & Category Fluency Test | baseline,24 months |
| CDR- Measurements to Assess General Cognitive Function | Changes in Global Clinical Dementia Rating (CDR) score (sum of boxes) | baseline,24 months |
| MoCA- Measurements to Assess General Cognitive Function | Changes in Montreal Cognitive Assessment (MoCA) | baseline,24 months |
| Clock Drawing test- Measurements to Assess General Cognitive Function | Changes in the Clock Drawing test | baseline,24 months |
| Logical Memory test- Measurements to Assess General Cognitive Function | Changes in the Logical Memory test | baseline, 24 months |
| Digit Span Forward & Backward test- Measurements to Assess General Cognitive Function |
| Measure | Description | Time Frame |
|---|---|---|
| NeuroImaging | Changes in brain Magnetic Resonance Imaging (MRI) 1.5 Tesla (brain atrophy) | baseline,24 months |
| CSF - beta amyloid | Changes in mean values on high sensitivity beta-amyloid 1-42 protein |
| Measure | Description | Time Frame |
|---|---|---|
| Weight in Kilograms | Changes in weight | baseline,24 months |
| Height in Meters | Changes in Height | baseline,24 months |
Inclusion Criteria:
Exclusion Criteria:
Excluded Medication:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Greek Associoation of Alzheimer'S Disease and Related Disorders | Thessaloniki | 54248 | Greece |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 27472878 | Result | Tsolaki M, Karathanasi E, Lazarou I, Dovas K, Verykouki E, Karacostas A, Georgiadis K, Tsolaki A, Adam K, Kompatsiaris I, Sinakos Z. Efficacy and Safety of Crocus sativus L. in Patients with Mild Cognitive Impairment: One Year Single-Blind Randomized, with Parallel Groups, Clinical Trial. J Alzheimers Dis. 2016 Jul 27;54(1):129-33. doi: 10.3233/JAD-160304. | |
| 31802059 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000544 | Alzheimer Disease |
| ID | Term |
|---|---|
| D003704 | Dementia |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D038441 | Diet, Mediterranean |
| ID | Term |
|---|---|
| D000095500 | Diet, Plant-Based |
| D004035 | Diet Therapy |
| D044623 | Nutrition Therapy |
| D013812 | Therapeutics |
Not provided
Not provided
Single Participant
Not provided
Not provided
single (participant)
| Mediterranean Diet | Other | Mediterranean Diet ,for a personal nutrition with the same dietary habits |
|
Changes in the Digit Span Forward & Backward test |
| baseline,24 months |
| WAIS-R (Wechler Adult Intelligence scele) Digit Symbol- Measurements to Assess General Cognitive Function | Changes in the WAIS-R Digit Symbol Substitution Test | baseline,24 months |
| TMT(Trail Making Test) part A and B- Measurements to Assess General Cognitive Function | Changes in the Trail Making Test | baseline, 24 months |
| ADASCog-Measurements to Assess Daily Functionality | Changes in Alzheimer's Disease Assessment Scale-Cognitive (ADASCog) Score scale:0-70,cut off:<15 | baseline, 24 months |
| Functional Rating Scale for Dementia-Measurements to Assess Daily Functionality | Changes in Functional Rating Scale for Dementia (FRSSD) Score scale:0-6,cut off:>6 | baseline, 24 months |
| Auditory Verbal Learning Test- Measurement to Assess Verbal Fluency and Learning | Changes in the Auditory Verbal Learning Test | baseline,24 months |
| baseline,24 months |
| CSF(cerebrospinal fluid) TAU-protein ( soluble protein) | Changes in mean values on TAU-protein in cerebrospinal fluid | baseline,24 months |
| Electroencephalography recording | Changes in Electroencephalography (EEG), resting state.The device records brain signals through 57 electrodes, 2 reference electrodes attached to the earlobes, and a ground electrode placed at a left anterior position | baseline,24 months |
| Tzekaki EE, Tsolaki M, Pantazaki AA, Geromichalos G, Lazarou E, Kozori M, Sinakos Z. Administration of the extra virgin olive oil (EVOO) in mild cognitive impairment (MCI) patients as a therapy for preventing the progress to AD. Hell J Nucl Med. 2019 Sep-Dec;22 Suppl 2:181. |
| D024801 |
| Tauopathies |
| D019636 | Neurodegenerative Diseases |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |
| D004032 |
| Diet |
| D009747 | Nutritional Physiological Phenomena |
| D000066888 | Diet, Food, and Nutrition |
| D010829 | Physiological Phenomena |